Walter Reed Army Medical Center

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, Walter Reed Army Medical Center sits in the top decile of US sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count).

24 total trials none currently recruiting 22 completed later-stage tilt top decile by trial count

Walter Reed Army Medical Center: 24 sponsored US clinical trials, none currently recruiting.

Walter Reed Army Medical Center sponsors 24 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 22 completed. 4 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hyperthyroidism, with 1 trials.

Top-decile sponsor footprint

Walter Reed Army Medical Center ranks in the top decile of sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 69/100

22 of 24 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

24 total, page 1 of 1

COMPLETED Phase 1

FluMist in Egg Allergic Patients

NCT01248208
COMPLETED NA

Oral Gabapentin Versus Placebo for Treatment of Postoperative Pain Following Photorefractive Keratectomy

NCT00793910
COMPLETED

Normal Lacritin Levels in Human Tears- Development of a New Clinical Assay

NCT00487643
COMPLETED NA

Fluticasone Versus Esomeprazole to Treat Eosinophilic Esophagitis

NCT00895817
COMPLETED Phase 4

Continuous Positive Airway Pressure (CPAP) Promotion And Prognosis - the Army Sleep Apnea Program (ASAP)

NCT00612157
COMPLETED NA

Acupuncture Treatment of Dry Eye

NCT00554879
COMPLETED NA

Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization

NCT00512876
COMPLETED Phase 4

Ezopiclone Improves the Quality of Overnight Polysomnography

NCT00507117
COMPLETED NA

Evaluation of Epi-lasik in U.S. Army Personnel

NCT00413517
TERMINATED Phase 4

Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis

NCT00397657
COMPLETED

PASSION - P Trial: Ph Adjusted Sulfur-Colloid, Sentinel Initiative ON Pain Trial

NCT00940199
COMPLETED Phase 3

Sequential Compression Devices for Treatment of Restless Legs Syndrome

NCT00479531
COMPLETED

Visual Prognosis in Non-Penetrating Corneal Blast Injuries

NCT00414219
COMPLETED

Coexisting Thyroid Disease and Hyperparathyroidism

NCT01306916
COMPLETED NA

A Prospective Comparison of Alcon LADARVision Wavefront-guided LASIK Enhancement and Conventional LASIK Enhancement for the Correction of Residual Refractive Errors Following LASIK Procedures

NCT00413881
COMPLETED NA

Federal Study of Adherence to Medications in the Elderly (FAME)

NCT00393419
TERMINATED NA

A Comparison of Photorefractive Keratectomy (PRK), PRK With Mitomycin-C and Laser Subepithelial Keratomileusis (LASEK) in the Treatment of Moderate and High Myopia

NCT00415077
COMPLETED

Warfarin and Coronary Calcification Project

NCT00868712
COMPLETED NA

Evaluation of Conventional Photorefractive Keratectomy (PRK) in U.S. Army Personnel, Substudy of: Initial Evaluation of Excimer Laser Keratorefractive Surgery in U.S. Army Personnel

NCT00412568
COMPLETED

A Prospective Randomized Study Comparing Sentinel Lymph Node (SLN) Evaluation With Standard Pathological Evaluation for the Staging of Colon Carcinoma

NCT01623258
COMPLETED NA

Initial Evaluation of Photorefractive Keratectomy in U.S. Army Personnel

NCT00413673
COMPLETED NA

A Prospective Evaluation of Contrast Sensitivity and Disability Glare in Refractive Surgery, a Sub-Study of: Initial Evaluation of Excimer Laser Keratorefractive Surgery in U.S. Army Personnel (WU # 2335-99)

NCT00413868
COMPLETED NA

Comparison of the Effect of 4th Generation Fluoroquinolones, Gatifloxacin and Moxifloxacin, on Epithelial Healing Following Photorefractive Keratectomy (PRK), A Substudy of: Initial Evaluation of Excimer Laser Keratorefractive Surgery in U.S. Army Personnel (WU # 2335-99)

NCT00414011
COMPLETED

Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes

NCT00413751

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 1
Phase 4 3

Therapeutic Areas

Hyperthyroidism 1
Coronary Calcification 1
Myopia 1
Hyperlipidemia 1
Medication Adherence 1
Breast Cancer 1
Hypertension 1

How the Walter Reed Army Medical Center archive is shaped

24 indexed studies, none listed as recruiting (0% open); 22 completed (92%).

Phase mix: 4 late (III/IV) vs 1 early (I/II) (later-stage heavy).

Top condition: Hyperthyroidism (1 trial), 6 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Walter Reed Army Medical Center: archived-pipeline peers nationwide

Peers matched on 24 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Walter Reed Army Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015202530 0%10%20%30% Total trials Recruiting share Walter Reed Army Medical CenterAcrotech BiopharmaAgenusAkebia TherapeuticsBlueprint Medicines Corporation10xBio22nd Century Group23andMe3-C Institute for Social Development
Walter Reed Army Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Walter Reed Army Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 24 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Walter Reed Army Medical Center page

24 registered trials is a research-attention snapshot, not an endorsement of Walter Reed Army Medical Center or any single study.

  • None of Walter Reed Army Medical Center's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Hyperthyroidism is the condition Walter Reed Army Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hyperthyroidism trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Walter Reed Army Medical Center pipeline card: 24 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.